Top Companies in Generic Drugs Market | Top Key Players Future and Past Analysis, Statistics, Growth rate, Market Size & Share | Vantage Market Research
According to the US Food and Drug Administration (FDA), a generic drug is "designed to be the same as an existing approved brand-name drug in dosage form, security, strength, and method of administration, grade, and performance characteristics”.
Coralia.Joe
Market Overview:
The Global Generic Drugs Market is valued at USD 392.4 Billion in the year 2021 and is expected to reach a value of USD 531.8 Billion by the year 2028. The Global Market is anticipated to grow to exhibit a Compound Annual Growth Rate (CAGR) of 5.2% over the forecast period. A Generic Drug is a medication created to be the same as an already market brand-name drug in dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use. These drugs are cheaper and equivalent to branded drugs in dosage, strength, direction of the administration, quality, performance, and application. Generic Drugs are subjected to authorities' policies in numerous nations instead of being related to a specific company. As the global Generic Drugs Market is huge, it is very probable to retain development in the forecast period. The assumption is attributed to increasing in the increasing prevalence of chronic diseases, growth in the geriatric population, and growing healthcare expenditure.
Get Access to Our Free Sample Report: https://www.vantagemarketresearch.com/generic-drugs-market-1660/request-sample
Some of the key players operating in the Generic Drugs Market are listed below:
|
Company Name |
Revenue in the US |
|
$1 Billion |
|
$43 Billion |
|
$16 Billion |
|
$16 Billion |
|
$27 Billion |
|
$3 Billion |
|
$45 Billion |
|
$12 Billion |
|
$69 Billion |
|
$9 Billion |
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market, and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe, and the Rest of the World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of the World segment comprises operations in Japan, Australia, China, Brazil, Russia, India, South Africa, the Middle East, and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The company was founded by Wallace Calvin Abbott in 1900 and is headquartered in Abbott Park, IL.
Allergan a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company also offers breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. Allergan was founded in 1983 and is headquartered in Dublin, Ireland.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Stada Arzneimittel AG manufactures pharmaceuticals. The Company produces generics (products whose patents have expired), brand-name products, and cancer therapy and other special pharmaceuticals. Stada avoids cost-intensive research on active ingredients and concentrates on multi-source products. The Company markets its products worldwide. It was founded in 1895 and headquarter is in Germany.
GlaxoSmithKline PLC. is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas. The company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Sandoz International GmbH develops, produces, and distributes generic pharmaceuticals. The Company offers therapeutic products, generic anti-infective, biosimilars, oncology injectable, patches, inhalers, and oral solids. Sandoz International caters its products worldwide. It was founded in 1886 and its headquarter is in Switzerland.
Read Latest Blog Top Companies in Ethanol Market: https://v-mr.biz/ethanol-market
Do You Have Any Query or Specific Requirements? You may enquire to our sales team before purchase.
Contact us
Eric Kunz
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: [email protected]
Website: https://www.vantagemarketresearch.com/
Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/
Follow Us on Twitter: https://twitter.com/vantagemarketr
